Cardiovascular status after Kawasaki disease in the UK

V Shah1, G Christov2, T Mukasa2

  • 1Infection, Inflammation and Rheumatology Section, UCL Institute of Child Health, London, UK.

Insights

Endothelial injury markers persist long after Kawasaki disease (KD), even in children without coronary artery aneurysms (CAA). This indicates a need for long-term cardiovascular monitoring in all KD survivors.

Area of Science:

  • Cardiovascular Medicine
  • Pediatric Rheumatology
  • Vascular Biology

Background:

  • Kawasaki disease (KD) is a leading cause of acquired heart disease in children, potentially leading to coronary artery aneurysms (CAA).
  • Long-term cardiovascular outcomes for KD patients without CAA or with regressed CAA remain poorly understood.
  • Assessing endothelial injury and cardiovascular risk factors is crucial for understanding long-term sequelae.

Purpose of the Study:

  • To investigate long-term cardiovascular status in Kawasaki disease patients.
  • To examine the relationship between coronary artery status, endothelial injury markers, and cardiovascular risk factors post-KD.
  • To compare endothelial injury markers, pulse-wave velocity (PWV), and carotid intima-media thickness (cIMT) between KD patients and healthy controls.

Main Methods:

  • Compared circulating endothelial cells (CECs), endothelial microparticles (EMPs), and soluble cell-adhesion molecules between 92 KD patients and 51 healthy controls (HC).
  • Classified KD patients based on worst-ever coronary artery (CA) status: CAA present (CAA+) or absent (CAA-).
  • Assessed cardiovascular risk factors (CRF), PWV, and cIMT in both groups.

Main Results:

  • KD patients exhibited significantly higher CECs than HC, with the highest levels in the CAA+ group and elevated levels also observed in the CAA- group.
  • Endothelial microparticles (CD105 EMPs) and specific soluble adhesion molecules were elevated in KD patients, particularly in the CAA+ group.
  • No significant differences were found in PWV, cIMT, CRF, or systemic inflammation markers between KD patients and HC.

Conclusions:

  • Endothelial injury markers, such as CECs, persist for years following Kawasaki disease.
  • These markers of endothelial dysfunction are present even in KD patients who did not develop coronary artery aneurysms.
  • Long-term monitoring for endothelial injury is warranted in all Kawasaki disease survivors, irrespective of initial coronary artery status.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...